Orbis Biosciences Acquired

Lenexa-based Orbis Biosciences was purchased by New Jersey-based Adare Pharmaceuticals.

Adare made the purchase to improve its tech pharma business. 

“The acquisition by Adare will globalize the reach of our technologies and services,” said Maria Flynn, president and CEO of Orbis Biosciences. “Orbis’s focus on precision delivery solutions has enabled us to develop expertise in novel extended-release and pulsatile-release formulations and to collaborate with great partners. We are pleased to join Adare, an industry leader in drug formulation development and manufacturing.”

Read more here.